当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第21期
编号:12959118
噻托溴铵对慢性阻塞性肺疾病急性加重期患者动脉血气、肺功能、炎症因子的影响(4)
http://www.100md.com 2016年7月25日 《中国现代医生》 2016年第21期
     [15] Ying Wang,Knut Stavem,Fredrik A Dahl. Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD)[J]. International Journal of Chronic Obstructive Pulmonary Disease,2014,9(6):99-105.

    [16] Antonio M Esquinas,Marco Confalonieri. Anemia and health performance score evaluation as decisive factors for noninvasive mechanical ventilation decisions in AECOPD:Are there new key cornerstones[J]. International journal of chronic obstructive pulmonary disease,2014,9(8):151.

    [17] 王玮,皇甫秋强. 联合吸入噻托溴铵及沙美特罗丙酸氟替卡松治疗慢性阻塞性肺疾病的临床研究[J]. 中国基层医药,2015,43(2):282-284.

    [18] 陈宇清,廖若敏,徐红冰,等. 低剂量茶碱联合噻托溴铵对轻中度稳定期慢性阻塞性肺疾病患者肺功能及生命质量的影响[J]. 中国医师进修杂志,2015,38(4):235-240.

    [19] Jung Soo Kim,Jinkyeong Park,Seong Yong Lim,et al. Comparison of Clinical Efficacy and Safety between Indacaterol and Tiotropium in COPD:Meta-Analysis of Randomized Controlled Trials[J]. PloS One,2015,10(3):948.

    [20] Christian Vogelberg,PetraMoroni-Zentgraf,Migle Leonaviciute-Klimantaviciene. Arandomised dose-ranging study of tiotropium Respimat in children with symptomatic asthma despite inhaled corticosteroids[J]. Respiratory Research,2015,16(1):175.

    (收稿日期:2016-03-04), http://www.100md.com(张勇华)
上一页1 2 3 4